SCAN Haematology Group

Fiona Scott congratulated Sandra Bagnall, Peter McDade and Angus
Ogilvy on the work they had undertaken and suggested the following
actions:
• Provide feedback to reception staff
• Provide feedback to Kathryn Brechin on the lack of space in
Ward 1
• Brenda Peek to provide feedback to management on the
confidentiality issues in relation to the Ward 1 sign in book.
Action: Fiona Scott to provide feedback to reception staff and
Kathyrn Brechin on findings from the patient survey.
Fiona Scott
The Group agreed that it would be useful to conduct a survey about
the treatment expectations of older, frail patients. It was agreed that
Fiona Scott should work with Brenda Peek to develop a
questionnaire and seek help from Sandra Bagnall in taking the
survey forward.
Action: Fiona Scott and Brenda Peek to develop a
questionnaire for older, frail patients and seek help from
Sandra Bagnall in taking forward a survey for this patient
group.
Fiona Scott
Rosie Jones
Sandra Bagnall
• Chemotherapy Electronic Prescribing and Administration
System (CEPAS)
Brenda Peek reported that the rollout of CEPAS was progressing but
a number of teething problems had been encountered, including
delays in results on APEX being downloaded to CEPAS. As far as
haematology was concerned, Brenda said the major issue for her was
having time to work on the protocols and she said she would discuss
the possibility of taking professional leave at the next management
meeting.
4 Any other business
Lymphoma QPI Development Group – Fiona Scott advised that the
QPI Group was due to hold its first meeting on 7 th March.
Molecular Pathology Consortium Implementation Group – Fiona
Scott advised the Group that she and Ewan Brown had been nominated
to represent SCAN on a group which had been set up to discuss the
establishment of a national molecular pathology consortium. Group
members emphasised the importance of retaining the streamlined and
integrated diagnostic pathway for haematology and Fiona Scott undertook
to highlight this at the national group. It was agreed that Fiona should
report back to the Haematology Group at alternate meetings.
Cytogenetics – Peter Williamson reported that cytogenetics had agreed
to a one-month trial of email notifications. It was agreed that if the pilot
proved successful, other clinicians would also be keen to receive email
alerts.
Page 4 of 5